Pathophysiology Practice Exam Related

Review Pathophysiology Practice Exam related questions and content

A patient is being treated with raloxifene (Evista) for osteoporosis. What should the nurse teach the patient about this medication?

  • A. It is used as a selective estrogen receptor modulator to prevent bone loss.
  • B. It works by decreasing bone formation and increasing bone resorption.
  • C. It should be taken with food to reduce gastrointestinal side effects.
  • D. It may cause weight gain and fluid retention.
Correct Answer: C

Rationale: The correct answer is C. Raloxifene is a selective estrogen receptor modulator (SERM) used to prevent bone loss. It should be taken with food to reduce gastrointestinal side effects, not on an empty stomach. Choices A and B are incorrect because raloxifene is indeed a SERM that prevents bone loss, but it does not directly work by increasing bone formation or decreasing bone resorption. Choice D is incorrect as weight gain and fluid retention are not common side effects of raloxifene.